REGENXBIO Inc. (RGNX): Price and Financial Metrics
RGNX Price/Volume Stats
Current price | $7.30 | 52-week high | $28.80 |
Prev. close | $7.32 | 52-week low | $6.56 |
Day low | $7.23 | Volume | 700,800 |
Day high | $7.76 | Avg. volume | 1,002,427 |
50-day MA | $8.00 | Dividend yield | N/A |
200-day MA | $11.10 | Market Cap | 361.68M |
RGNX Stock Price Chart Interactive Chart >
REGENXBIO Inc. (RGNX) Company Bio
REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. The company was founded in 2009 and is based in Rockville, Maryland.
RGNX Price Returns
1-mo | -0.95% |
3-mo | -28.08% |
6-mo | -38.50% |
1-year | -61.23% |
3-year | -71.65% |
5-year | -86.33% |
YTD | -5.56% |
2024 | -56.94% |
2023 | -20.86% |
2022 | -30.64% |
2021 | -27.91% |
2020 | 10.72% |
Continue Researching RGNX
Want to do more research on REGENXBIO Inc's stock and its price? Try the links below:REGENXBIO Inc (RGNX) Stock Price | Nasdaq
REGENXBIO Inc (RGNX) Stock Quote, History and News - Yahoo Finance
REGENXBIO Inc (RGNX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...